Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-122143
Filing Date
2010-05-17
Accepted
2010-05-17 16:15:39
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 208167
2 FORM OF 2007 DIRECTOR'S RESTRICTED STOCK AWARD AGREEMENT dex10o.htm EX-10.O 16969
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-15(F) dex311.htm EX-31.1 9214
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-15(F) dex312.htm EX-31.2 9191
5 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 6328
  Complete submission text file 0001193125-10-122143.txt   251391
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 10838742
SIC: 2834 Pharmaceutical Preparations